Cece Jr., Cesar L.
HRN: 24-02-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/10/2023
11/16/2023
IVT
500mg
Q8
T/c Hepatoma
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes